Abstract
Most of the systemic connective tissue diseases affect the respiratory system, most often — lung tissue, but due to the worldwide spread of the new coronavirus, lung lesions are often explained as this disease. It dictates the need to distinguish pulmonary lesion in COVID-19 and other pathological conditions of the lungs, despite similar clinical, laboratory and instrumental signs. A complex differential diagnosis of the etiological origin of lung lesion was carried out in patients with rheumatic diseases after the new coronavirus infection, which is very important during the SARS-Cov-2 pandemic due to the presence of opposite therapeutic tactics — increase or decrease of cytostatic treatment. The symptomatology and the course of lung disease are the most important for the differential diagnosis of these conditions, and computed tomography is the most important instrumental method of examination. Further study and clinical observation is needed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
